Eva Van Rooij

This inventor holds 23 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in MicroRNA Therapeutics. Top assignees: The University of Texas System, Miragen Therapeutics, Inc.. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Van Rooij. Retrieved from https://idiyas.com/inventor/eva-van-rooij

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 39.1

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 90(Granted Patents)

Location History:

Boulder, CO (US) (2013 - 2015)
Utretcht, NL (2017)
Utrecht, NL (2015 - 2019)
Ultrecht, NL (2017 - 2019)

Company Filing History:

15 out of 5,633

The University of Texas System

patents

9 out of 20

Miragen Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2013-2019

Loading Chart...

Areas of Expertise:

Micro-RNA

Extracellular Matrix

Oligonucleotide Inhibitors

Locked Nucleic Acid

Fibrosis Modulation

Cardiomyocyte Survival

Heart Failure

Energy Homeostasis

Myofiber Identity

miR-29

miR-15

Cardiac Disorders

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10392618 - Micro-RNA family that modulates extracellular matrix genes and uses thereof (2019-08-27),

2. 10337005 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif (2019-07-02),

3. 9994847 - miR-29 mimics and uses thereof (2018-06-12),

4. 9803202 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif (2017-10-31),

5. 9752143 - Locked nucleic acid inhibitor of miR-145 and uses thereof (2017-09-05),

6. 9719088 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

7. 9719087 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

8. 9719086 - Micro-RNA family that modulates fibrosis and uses thereof (2017-08-01),

9. 9428749 - Control of whole body energy homeostasis by microRNA regulation (2016-08-30),

10. 9388408 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif (2016-07-12),

11. 9376681 - miR-29 mimics and uses thereof (2016-06-28),

12. 9163235 - Inhibitors of the miR-15 family of micro-RNAs (2015-10-20),

13. 9078919 - Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair (2015-07-14),

14. 9072765 - Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure (2015-07-07),

15. 8962588 - Micro-RNAS that control myosin expression and myofiber identity (2015-02-24),

Title: Inventor Eva van Rooij - Revolutionizing Technology in Utrecht

Introduction: Eva van Rooij is a pioneering inventor based in Utrecht, Netherlands, known for her groundbreaking contributions to the field of technology.

Latest Patents: Eva van Rooij holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing her innovative spirit and forward-thinking approach.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Eva van Rooij has led numerous successful projects that have had a significant impact on the tech industry.

Collaborations: Throughout her career, Eva van Rooij has collaborated with leading research institutions, tech companies, and universities to further develop and implement her inventions, fostering a culture of innovation and progress.

Conclusion: Eva van Rooij's dedication to pushing the boundaries of technology and her relentless pursuit of excellence make her a true trailblazer in the world of inventions. Her work continues to inspire and shape the future of innovation in Utrecht and beyond.

Profile summary based on public USPTO records.